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Global Profiling of Alternative Splicing Events and Gene
Expression Regulated by hnRNPH/F
Erming Wang1, Vahid Aslanzadeh2, Filomena Papa1, Haiyan Zhu1, Pierre de la Grange3, Franca Cambi1*
1 Department of Neurology, University of Kentucky, Lexington, Kentucky, United States of America, 2 Department of Biotechnology, Research Institute of Physiology and
Biotechnology, University of Zanjan, Zanjan, Iran, 3 GenoSplice technology, Hôpital Saint-Louis, Paris, France

Abstract
In this study, we have investigated the global impact of heterogeneous nuclear Ribonuclear Protein (hnRNP) H/F-mediated
regulation of splicing events and gene expression in oligodendrocytes. We have performed a genome-wide transcriptomic
analysis at the gene and exon levels in Oli-neu cells treated with siRNA that targets hnRNPH/F compared to untreated cells
using Affymetrix Exon Array. Gene expression levels and regulated exons were identified with the GenoSplice EASANA
algorithm. Bioinformatics analyses were performed to determine the structural properties of G tracts that correlate with the
function of hnRNPH/F as enhancers vs. repressors of exon inclusion. Different types of alternatively spliced events are
regulated by hnRNPH/F. Intronic G tracts density, length and proximity to the 59 splice site correlate with the hnRNPH/F
enhancer function. Additionally, 6% of genes are differently expressed upon knock down of hnRNPH/F. Genes that regulate
the transition of oligodendrocyte progenitor cells to oligodendrocytes are differentially expressed in hnRNPH/F depleted
Oli-neu cells, resulting in a decrease of negative regulators and an increase of differentiation-inducing regulators. The
changes were confirmed in developing oligodendrocytes in vivo. This is the first genome wide analysis of splicing events
and gene expression regulated by hnRNPH/F in oligodendrocytes and the first report that hnRNPH/F regulate genes that are
involved in the transition from oligodendrocyte progenitor cells to oligodendrocytes.
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oligodendrocyte progenitor cells to differentiated OL, suggesting
that hnRNPH/F may contribute broadly to differentiationinduced changes in gene splicing and expression that occur as
part of the OL differentiation program.
Many excellent genomewide studies have characterized the role
of G tracts in splicing [6,7,14]. A global analysis of genome wide
hnRNPH/F mediated regulation of alternative splicing has been
conducted in human 293 T cells [15] and, for a relatively small
number of genes related predominantly to apoptosis and cancer, in
cancer cells [16]. In this study, we sought to investigate the global
impact of hnRNPH/F-mediated regulation of splicing events in
oligodendrocytes and to determine whether genes involved in OL
lineage progression are regulated by hnRNPH/F.
To this end, we have performed a genome-wide transcriptomic
analysis at the gene and exon levels in Oli-neu cells treated with
siRNA that target hnRNPH/F vs. untreated cells using Affymetrix
exon array platforms. Gene expression levels and regulated exons
were identified with the EASANA algorithm [17,18]. Bioinformatics analyses were performed to determine the structural
properties of G tracts, such as length, distance and position that
correlate with the enhancing vs. silencing effect of hnRNPH/F.
The expression of genes involved in signaling pathways was
regulated by hnRNPH/F. Genes that regulate the transition of
OPC to OL are differentially expressed in hnRNPH/F silenced

Introduction
hnRNPH and F control alternatively spliced events (ASE) by
binding to G tracts positioned in close proximity to the 59 or 39
splice sites (ss), with G triplets being the basic recognition motif
[1,2,3,4,5]. hnRNPH and F can either enhance or inhibit the
alternatively spliced exon and the magnitude of the effect is
dependent on the length of the G tracts, the intronic vs. exonic
position and the strength of the 59 ss [6,7,8,9,10]. We have shown
that hnRNPH/F regulate the major myelin proteolipid protein
(PLP)/DM20 ratio predominantly by enhancing the selection of
the DM20 59 splice site through long G tracts positioned in exon
3B immediately downstream of the DM20 59ss [11,12,13]. Unlike
other ASEs, hnRNPH and F exert a novel synergistic regulation of
the PLP alternatively spliced event and their function is not
redundant [12].
The alternative splicing of PLP is a differentiation dependent
event in the oligodendrocytes (OL), the myelin producing cells of
the central nervous system (CNS). Endogenous hnRNPH and F
expression is high in oligodendrocyte progenitor cells (OPC) and
decreases in differentiated OL in vitro at the time when the PLP/
DM20 ratio increases [12]. Furthermore, siRNA-mediated knock
down of hnRNPH/F increases the PLP/DM20 ratio in the
oligodendrocyte cell line, Oli-neu cells [12]. The down regulation
of hnRNPH/F is temporally related to the transition of
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ue#0.05 for the low confidence. Exons and part of exons were
considered statistically significant for P-values #0.05 and foldchanges $1.2 for both high and low confidences.

Oli-neu cells. These changes were confirmed in developing OL
in vivo.
This is the first genome wide analysis of splicing events and
genes differentially regulated by hnRNPH/F in OL and the first
report that hnRNPH/F regulate genes involved in the transition
from OPC to OL.

Pathway Analysis
Significant KEGG pathways [23] were retrieved using DAVID
[24].

Materials and Methods
RT-PCR and Real time qRT-PCR

Cell Cultures, Transfections and Primary Oligodendrocyte
Cell Isolation

Total RNA was extracted with the RNeasy mini kit according to
the manufacturer’s instructions (Qiagen). The sequences of
primers used for semiquantitative RT-PCR and for Real Time
RT-PCR are shown in Table S1 and Table S2, respectively. qRTPCR was performed using the StepOneTM real-time PCR system
(Applied Biosystems) at the University of Kentucky Spinal Cord
and Brain Injury Research Center core facility, as described
[25,26], and data was analyzed by the StepOneTM Software v2.0
(Applied Biosystems). Relative RNA levels were determined by
comparing threshold cycles for individual RNA products normalized with GAPDH using the 22DDCT method [27].

Oli-neu cells [19] were grown in SATO medium, as described
[12,19]. Oli-neu cells were transfected with 80 nM of siF/H,
which targets both hnRNPH and F using the siPORT Amine
reagents (Applied Biosystems) and cultured in growth medium for
72 hrs [12]. Total RNA was prepared and submitted for
microarray analysis (Microarray Core Facility, University of
Kentucky). Cell suspensions were prepared from the CNP-EGFP
mouse brains (kind gift of Dr. V. Gallo) and EGFP+ OLs were
isolated by Fluorescent Activated Cell Sorting (FACS) (FACS
facility, University of Kentucky), as previously described [20,21].
The animal work was approved by Institutional Animal Care
and Use Committee at the University of Kentucky and was
conducted in adherence with the University’s guidelines for
animal husbandry.

Results
hnRNPH and F Promote Both Exon Inclusion and
Skipping
To investigate the global role of hnRNPH/F in the regulation of
splicing events, we have performed a genome wide analysis of exon
levels in Oli-neu cells that were treated with an siRNA, siF/H,
which targets both hnRNPH and F, compared to mock siRNA
treated cells. As previously published, treatment of Oli-neu cells
with 80 nM siF/H reduces hnRNPH/F expression greater than
70% (Fig. 1B and [11]), which results in a two-fold increase in the
PLP/DM20 ratio derived from the endogenous PLP transcript
(Fig. 1A, [11]).
The exon levels were classified into high and low confidence
groups (see Methods). Splicing of 252 exons was differentially
regulated by knock down of hnRNPH/F in the high confidence
group and 1,649 exons were differentially regulated by knock
down of hnRNPH/F in the low confidence group. After manually
inspecting the 252 exons from the high confidence group,
individual types of alternatively spliced events were assessed. We
found four intron retention (2%), twelve 59/39 ASEs (5%), 26
alternative first exon (10%), 41 alternative terminal exon (16%), 18
cassette exons (7%) and 151 unknown internal alternative splicing
events (60%) (Fig. 1C, 1D).
The data show that hnRNPH/F regulate different types of
alternative spliced events, indicating a broad role in the regulation
of alternative splicing. In addition, in four of the six defined
categories of ASEs, alternative first, alternative terminal,59/39
alternative splicing and cassette exons, there are more events that
are excluded upon depletion (hnRNPH/F-activated) vs. those that
are included (hnRNPH/F-repressed) upon depletion (Fig. 1D).

Affymetrix Exon Array Data Analysis
RNA was prepared using the RNeasy mini kit (Qiagen) from
triplicate experimental and control mock siRNA treated Oli-neu
cells. Five micrograms of total RNA were used to generate probes
to hybridize with the Affymetrix Mouse Exon 1.0ST Array
featuring , 1 million exon clusters and 1.4 million probe sets
(Microarray Core Facility, University of Kentucky). Since exon
arrays contain multiple probes per exon, we were able to analyze
both splicing and transcript levels.
Microarray dataset analysis and visualization were made using
EASANAH (GenoSplice technology), which is based on the
GenoSplice’s FAST DBH annotations [18]. Data were normalized
using quantile normalization. Background corrections were made
with antigenomic probes and probes were selected as described
previously [22]. Only probes targeting exons annotated from
FAST DBH transcripts were selected to focus on well-annotated
genes whose mRNA sequences are in public databases [17].
Probes whose intensity signal was too low compared to antigenomic background probes with the same GC content were
removed from the analysis. Only probes with a DABG P value
#0.05 in at least half of the arrays were considered for statistical
analysis [22]. Only genes expressed in at least one compared
condition were analyzed. To be considered as being expressed, the
DABG P-value had to be #0.05 for at least half of the gene
probes.
We performed a paired Student’s t-test to compare gene
intensities in the different biological replicates. Statistical analyses
were also performed using the Student’s paired t-test on the
splicing index to analyze the Exon Array data as described
previously [22]. The splicing index corresponds to a comparison of
gene-normalized exon intensity values between the two analyzed
experimental conditions [22]. Exon and gene expression levels
were classified in two groups indicated as high and low confidence.
Bad-quality selected probes (e.g., probes labeled by Affymetrix as
‘cross-hybridizing’) were removed from the analysis for the high
confidence. For gene level analysis, genes were considered
significantly regulated when fold-change was $1.5 and P value
#0.05 for the high confidence and fold-change$1.2, P valPLOS ONE | www.plosone.org

Mechanisms of hnRNPH and F Mediated Regulation of
ASE
In the case of 59 alternatively spliced events, the proximal site is
preferentially utilized [28,29]. To gain insights into the mechanisms by which hnRNPH/F regulate selection of competing 59 ss,
we have conducted a thorough analysis of the 59 ASEs that were
identified in both the high and low confidence groups. We
concentrated on the 59 ASEs since the PLP alternative splicing is
regulated by selection of competing 59 ss through hnRNPH/F
([12] and Fig. 1A). We first validated fourteen (3 from the high
2
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Figure 1. Genome wide analysis of alternative spliced events (ASEs) regulated by hnRNPH/F. Oli-neu cells were treated with an siRNA,
siF/H that targets both hnRNPH and F [12]. RNA was used to generate probes to hybridize with the Affymetrix Mouse exon 1.0ST array featuring , 1
million exon clusters and 1.4 million probe sets. We have analyzed splicing and transcript levels using the EASANAH from GenoSplice technology
(www.genosplice.com). A. RT-PCR amplification of the endogenous PLP and DM20 transcripts. Schematic of the PCR products is shown. siF/H
treatment induces a two-fold increase in the inclusion of exon 3B. Percent inclusion of exon 3B is shown. B. Western blot analysis of hnRNPH and F
expression. More than 70% reduction of hnRNPH/F is induced by the siF/H treatment. hnRNPA1 is used as loading control. C. Pie chart showing the
ASEs regulated by hnRNPH/F. Splicing of 252 exons was differentially regulated by knock down of hnRNPH/F. The types of spliced events are shown.
D. Pie charts show the relative abundance of included (hnRNPH/F-repressed) and excluded (hnRNPH/F-activated) exons. For four of the six categories
of alternative spliced events a greater number of exons are excluded (i.e. hnRNPH/F-activated) by depletion of hnRNPH/F. E. RT-PCR of alternative 59
splice sites. Representative RT-PCR of 59ASEs that were examined by semiquantitative RT-PCR analysis in siF/H treated vs. untreated Oli-neu cells
(mock) (n = 3). Each ASE is labeled with the gene ID and the alternative spliced exon (ae) is shown. The ASEs that were validated by RT-PCR are shown
in bold. The others, not bolded, demonstrated a change that was in the opposite direction of that detected in the arrays. Bar graphs represent the
percent change of the exon inclusion 6 SD in the siF/H treated cells vs. untreated cells set at 1 (n = 3). *#0.05 and **#0.01.
doi:10.1371/journal.pone.0051266.g001

ASEs did not have any G tracts in the downstream intron (Table
S3). One (NM_183151, Mid1) could not be consistently amplified
by RT-PCR, the other two were validated, however, for one
(NM_144842, MYM type 5) the changes were not statistically
significant while for the other (unknown gene, ae12) the changes
were robust (see Figure 1E for RT-PCR results). The absence of G
tracts suggests that these ASEs are not directly regulated by
hnRNPH/F. In all the others, G tracts were present, suggesting a
direct effect by hnRNPH and F.
The intron of the hnRNPH/F-activated exons contains on
average five G tracts (1–11), of which 25% are quadruplets (11),
6% are quintuplets (3), 2% are sixtuplets (1) and the remainder is
G triplets (Table S3). The intronic G tracts for the hnRNPH/Frepressed exons are on average 5 (3–6) of which 5% are
quadruplets and quintuplets. Exonic G tracts are more represented
in the hnRNPH/F-repressed exons (1–5), while fewer G tracts
were present in the hnRNPH/F-activated exons (0–4) (Table S3).
The differences in exonic and intronic G tracts between
hnRNPH/F-activated and hnRNPH/F-repressed exons are statistically significant (p-value 1.29613E-19, Fisher’s exact test).
Although the number of ASEs regulated by hnRNPH/F in the

confidence group and 11 from the low confidence group) 59 ASEs
by semiquantitative RT-PCR using primers that span the
alternatively spliced exons (Table S1). For 3 hnRNPH/F-activated
exons, we could not adequately amplify the alternative spliced
products, hence we have further analyzed the remainder 11 59
ASEs (data not shown). In three 59 ASEs, the inclusion of the
alternatively spliced exon is increased by knock down of
hnRNPH/F, while in eight ASEs the inclusion is decreased
(Fig. 1E). We confirmed the changes in exon inclusion/exclusion
by RT-PCR in 73% (8 out of 11) of the ASEs (Fig. 1E, indicated in
bold). These include one ASE in the hnRNPH/F-repressed exons
and seven in the hnRNPH/F-activated exons (Fig. 1E). The
changes in three ASEs (Fig. 1E, indicated in non bold characters)
are in the opposite direction of that detected in the arrays. The
data indicate that hnRNPH/F most often enhance the alternatively the spliced exon.
To determine whether the presence, position and length of the
G tracts correlate with the outcome of splicing and allow a
prediction of the effect mediated by hnRNPH/F, we have
examined the G tracts in the alternatively spliced exon and in
the downstream intron. Only three of the hnRNPH/F-activated
PLOS ONE | www.plosone.org
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hnRNPH/F-activated and -repressed 59 ss without significant
differences between the activated vs. repressed exons (data not
shown). Together, the data show higher density and length of G
runs in the intron downstream of the hnRNPH/F-activated exons,
consistent with their role as ISE.
Next, we have examined the G tract dependence on the 59 ss
strength and the functional outcome on the regulated exon.
Greater clustering of intronic G triplets occurs at intermediate 59 ss
(4–8 bits) vs. strong 59 ss (8–12 bits) for hnRNPH/F-activated and
-repressed exons considered as a group (Fig. S1). The FD of G
triplets was higher for hnRNPH/F-activated vs. hnRNPH/Frepressed exons for both intermediate and strong 59ss (Fig. 3C and
3D). However, the FD of intronic G triplets was 2–8 fold greater
for intermediate 59 ss compared to strong 59 ss (Fig. 3C and 3D), in
keeping with the dependence of ISE activity on the strength of the
59 ss [7].
The data indicate that the density and length of the G tracts
within the first 70 nucleotides of the intron is associated with
hnRNPH/F-dependent enhancement of the upstream 59 ss. This
effect is independent from the strength of the 59 ss, although the
clustering of intronic G tracts is higher for intermediate 59 ss, in
keeping with an evolutionarily conserved role of G tracts as
enhancers of weak 59 splice sites [7]. The presence of G tracts in
the exonic sequences does not show a clear association with either
an enhancer or silencer effect by hnRNPH/F.

arrays is small, the data suggest that high density and length of the
intronic G tracts and a relative paucity of exonic G tracts correlate
with enhancement of the proximal 59 ss by hnRNPH/F. In
contrast, a balanced distribution of exonic and intronic G tracts is
associated with inhibition of exon inclusion by hnRNPH/F. The
latter may result from either silencing of the proximal 59 ss or
enhancement of the distal 59 ss mediated by the exonic G tracts.
We have shown that hnRNPH and F play distinct roles in the
regulation of the PLP/DM20 ratio and cooperatively regulate the
PLP exon 3B inclusion [11,12]. Here, we sought to determine
whether hnRNPH and F have a similar effect in the regulation of
the 59 ASEs identified in the arrays. For this analysis, we selected
the ASEs whose changes were found to be statistically significant
by RT-PCR analysis, as shown in Figure 1E. We have measured
exon inclusion/exclusion for the 59 ASEs by semiquantitative RTPCR after silencing of hnRNPH and hnRNPF individually and
compared it to the effect of silencing both. Importantly, knock
down of either hnRNPH or F does not influence the abundance of
the other as well as the expression of other hnRNPs [12], hence,
the individual effect on the ASE can be measured separately in
these reactions. The PLP/DM20 ASE was used as control (Fig. 2).
The fold change in the inclusion of PLP exon 3B is 12 fold
compared to 2 fold with siH and no change with siF, as previously
shown [12]. For all ASEs, silencing hnRNPH and F individually
had a modest effect and silencing both resulting in a greater
change in the inclusion of the regulated exon, suggesting that in
general they have a redundant function (Fig. 2).
In summary, hnRNPH and F most commonly enhance the
inclusion of exons regulated by competing 59 ss and this effect
correlates with the density and length of intronic G tracts.
Generally, hnRNPH and F are functionally redundant and their
combined effect is additive.

hnRNPH and F Regulate Expression of Genes Involved in
OL Differentiation
Knock down of hnRNPH/F affected 6% of the expressed genes
in the low confidence group (832 transcripts out of 12,948
expressed genes). Of the regulated genes, 23% (188) were more
expressed and 77% (644) were less expressed in the low confidence
group. Among the 832 regulated genes, 131 (‘‘low confidence
group’’) (16%) also gather at least one differentially regulated exon,
while of the 12,948 expressed genes, 1,204 (9%) gather at least one
differentially regulated exon (‘‘low confidence group’’). The data
show an enrichment of differentially regulated exons in the genes
whose expression is affected by silencing hnRNPH/F.
A goal of this study was to determine whether hnRNPH and F
control the expression of genes that are important for OL cell
biology. By KEGG pathway analysis [23], we found that there was
an enrichment of genes that are involved in the insulin-IGF
signaling pathway, mTOR pathway, RNA binding proteins and
cell cycle (Fig. 4A). Because of the relevance of these pathways in
OL lineage progression, we have selected a number of genes and
validated the expression changes by Real Time qRT-PCR in Olineu cells after knock down of hnRNPH/F. We have selected 15
genes involved in OL lineage progression (Table S5). We have
validated approximately 60% of the differentially expressed genes
(Fig. 4B and Table S5). IGF1 level was found to be significantly
increased in the arrays, but was found to be decreased by Real
Time qRT-PCR analysis (Fig. 4B). Other genes that are involved
in cell cycle progression (cdk2) and negative regulator of OPC
differentiation (SOX6) were reduced both in arrays and by Real
Time qRT-PCR analysis (Fig. 4B). Splicing of a constitutive exon
is differentially regulated by depletion of hnRNPH/F along with
changes in expression of cdk2, SOX6 and hnRNPA2/B1,
suggesting that an effect in splicing may be coupled with the
change in expression (Table S5 and Discussion). In support of this
possibility, CLIP-Seq tags were identified in cdk2 [7], while SOX6
was shown to be regulated by hnRNPF [15].
To demonstrate the biological relevance of the gene expression
changes induced by hnRNPH/F knock down, we have quantified
their expression in developing OL in vivo. We have isolated OPC,

Gene Structure and G Tracts Determine the hnRNPH/F
Regulation of ASEs
Next, we sought to examine the G tract structural properties for
internal exons, which account for 67% of the hnRNPH/F
regulated ASEs in the arrays (in the high confidence group). We
have performed a bioinformatics analysis of the distribution and
length of intronic and exonic G tracts and correlated these features
with the functional outcome. Of 169 internal exons (i.e., cassette
exon and/or unknown internal alternative events) inclusion of the
regulated exon is reduced in 83 ASEs while it is increased in 86
ASEs. We have characterized G tracts in sequences extending
from +11 to +150 of the intron downstream of the regulated 59 ss
and from 211 to 2150 of the exon upstream of the regulated 59
ss. We have excluded sequences between +1 and +10 since G
tracts in this position overlap with the 59 splice site and were
shown to function as silencers [7] and enhancers [11]. The
frequency difference (FD) plot of G triplets was calculated as
previously described [10]. The highest FD is between +11 and +70
in the intron of both hnRNPH/F-repressed and hnRNPH/Factivated exons, however, the FD is 1–5 folds greater in
hnRNPH/F-activated vs. -repressed exons (Fig. 3A). Furthermore,
G quadruplets or longer G tracts are more commonly clustered
between +11 and +40 and are more abundant in hnRNPH/Factivated exons (Fig. 3B). Additionally, G runs are within 30
nucleotides from the 59 ss in 44 of the hnRNPH/F-activated exons
compared to 20 of the hnRNPH/F-repressed exons (Table S4). G
runs are positioned closer to each other, especially the first and
second G run, are separated by , = 20 nucleotides and contain
longer runs of Gs in the hnRNPH/F-activated vs. –repressed
exons (Table S4). The FD plot of G triplets in the upstream exon
sequences shows an overall lower G triplet representation in both
PLOS ONE | www.plosone.org
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Figure 2. Changes in exon inclusion induced by silencing hnRNPH and F individually vs. both simultaneously. Representative RT-PCR
(n = 2) of the products derived from 59ASEs in Oli-neu cells treated with siRNAs that target hnRNPH (siH), hnRNPF (siF) or both (siF/H). We selected
ASEs that were shown to have a statistically significant change in exon inclusion by RT-PCR. Mock are control untreated Oli-neu cells. Each ASE is
labeled with the gene ID number and the ae is shown (also refer to Figure 1E). The number shown below each lane represents the fold change in
exon inclusion compared to the mock treated cells set at the value of 1. The PLP/DM20 splicing event shows the synergistic effect of hnRNPH/F knock
down.
doi:10.1371/journal.pone.0051266.g002

Differential expression of these genes in p21 OL is associated
with a dramatic reduction in the abundance of hnRNPH and F in
p21 OL vs. p1 OPC (Fig. 5A). Furthermore, the fold change of the
selected genes measured in the arrays is similar to those that occur
in vivo. Notably, IGF1 is up-regulated in the arrays and in
differentiated p21 OL, however, it was reduced at p10, similarly to
the results in Oli-neu cells treated by siF/H (compare Fig. 4B with
Fig. 5B).
In summary, knock down of hnRNPH/F reduces the expression
of negative regulators of OL differentiation while it increases the
expression of differentiation inducing genes, replicating changes
that occur in developing OL in vivo. The data suggest that
hnRNPH/F may participate in the regulation of OL lineage
progression.

pre-OL and differentiated OL by sorting EGFP+ oligodendrocyte
lineage cells at post-natal day 1, 10 and 21 respectively, as
described [21]. We have quantitated the expression levels of IGF1,
which plays a pivotal role in OL survival and differentiation [30],
SOX6, which is a negative regulator of OL differentiation [31],
CREB3 which is a critical transcription factor and a target of the
differentiation inducing cAMP pathway [32], cdk2, which
regulates cell cycle progression in OL terminal differentiation
[33,34], hnRNPA2/B1, which regulates transport and translation
of the myelin basic protein in differentiated OL [35,36] and U2AF
which is an essential spliceosomal factor [37]. The expression of
IGF1, CREB3 and hnRNPA2/B1 increases in p21 day OL, while
levels of SOX6 and cdk2 decrease at p21 vs. p1 OPC (Fig. 5B).
U2AF, a spliceosomal factor is lower in p21 OL. The changes in
the expression of these genes in p21 OL vs. P1 OL were similar to
those detected by arrays, the fold change in the arrays is indicated
in parenthesis in Figure 5. The expression levels in p10 OL
showed different patterns for each gene examined. In the case of
IGF1 and hnRNPA2/B1, there was a decrease at p10 compared
to an increase at p21, cdk2 expression did not change at p10, but
was significantly decreased at p21, while SOX6 was drastically
decreased at p10. The data suggest that these genes have distinct
temporal regulation reflecting different roles in development.

PLOS ONE | www.plosone.org

Discussion
Our study is the first to examine the global impact that knock
down of hnRNPH and F has on alternative splicing and gene
expression in a brain derived oligodendrocytic cell line. We show
that hnRNPH/F regulate different types of alternative splicing and
the most common outcome caused by depletion of hnRNPH/F is
reduced inclusion of the alternatively spliced exon suggesting a
role as enhancers except for internal exons. In addition, our studies
5
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Figure 3. Frequency difference (FD) plot of G tracts in the intron downstream of internal cassette exons. A. FD plot of intronic G triplets
for decreased inclusion (down regulated) and increased inclusion (up regulated) 59 splice sites (ss). FD is defined as the difference between the
observed frequency of GGG in introns, calculated in a 30-nt window, and the mean frequency of GGG in 10 random permutations of the sequence in
the same window, with an offset of 3nt between successive windows, as described [10]. Black bars show the standard errors. B. FD plot of intronic G
quadruplets and longer G tracts for down and up regulated 59 ss. C. FD plot of G triplets in the intron downstream of intermediate and strong 59 ss of
exons with decreased inclusion (hnRNPH/F-activated). D. FD plot of G triplets in the intron downstream of intermediate and strong 59 ss of exons
with increased inclusion (hnRNPH/F-repressed).
doi:10.1371/journal.pone.0051266.g003

reflect differences in the mechanism by which hnRNPH/F
activate vs. repress splicing.
We have concentrated on the 59 alternative spliced events as this
is the mechanism that regulates alternative splicing of the PLP
gene by hnRNPH/F in oligodendrocytes. High density and length
of the intronic G tracts and a relative paucity of exonic G tracts
correlate with enhancement of the proximal 59 ss by hnRNPH/F.
In contrast, a balanced distribution of exonic and intronic G tracts
is associated with inhibition of exon inclusion. These results are
consistent with the knowledge that intronic G runs function as
ISE, while exonic G runs function as silencers [38].
The higher G peaks close to the 59 ss and the greater density
close to weak 59 ss was previously reported in genome wide studies
[7,9,10]. Our study shows that there is a selective clustering of G
runs associated with the role of hnRNPH/F as enhancers vs. a
function as repressors. How might the higher density of G runs
and the greater length favor the role of hnRNPH/F as enhancers?
Clustering close to the 59 ss is thought to reflect an optimal
distance required for the splicing factors to interact with the
spliceosome [10]. Interestingly, binding of hnRNPH/F to G runs
through the qRRMs prevents formation of G mediated RNA
secondary structure [39]. Upon binding of hnRNPH/F, the higher

have uncovered a previously unrecognized function of hnRNPH/
F in the regulation of gene expression. Importantly, a significant
number of differentially expressed genes are components of
signaling pathways that regulate differentiation of oligodendrocytes, hence, positioning hnRNPH/F in the regulatory network
that control oligodendrocyte lineage progression.
Although hnRNPH/F are typically considered repressors of
alternative splicing, we show that knock down of both results in
decrease of the exon inclusion for four of the six categories of
spliced events examined consistent with enhancer function. We
conducted a careful analysis of the distribution, density and length
of the G runs in the intron downstream and the exon upstream of
the regulated 59 ss. hnRNPH/F regulated genes have a higher
frequency distribution of intronic G triplets in keeping with the
known function of G triplets as the basic binding motif for
hnRNPH/F and the G run ISE activity [7]. In both internal exons
and 59 alternative spliced events, there is a greater clustering of G
triplets and a higher representation of longer G tracts in the intron
downstream of the regulated 59 ss in genes that are enhanced vs.
those that are repressed by hnRNPH/F. The relative higher
density of intronic G triplets, especially between +11 and +30
nucleotides, in genes enhanced vs. repressed by hnRNPH/F may
PLOS ONE | www.plosone.org
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Figure 4. Genes are differentially regulated at the transcriptional levels. A. Representation of significant pathways whose genes are
affected by knock down of hnRNPH/F. Thirty one Kegg pathways were significantly affected. Genes are either up- or down-regulated. B. Changes in
gene expression were verified by Real Time RT-PCR in Oli-neu cells depleted of hnRNPH and F. Bar graphs represent the mean6SD of transcript levels
of the indicated genes quantitated by Real Time RT-PCR in mock siRNA treated (Mock) and siF/H treated Oli-neu cells (n = 3). Oli-neu cells were
treated with siF/H and harvested after 72 hrs in culture for Real Time RT-PCR analysis. The data are expressed as percent change of the treated vs.
mock cells, the latter is set at the value of 1. ns = non significant, *p = 0.05. In parenthesis next to the gene name is shown the fold change in the
microarrays.
doi:10.1371/journal.pone.0051266.g004

number of G runs may generate a more ‘‘open’’ RNA structure
which enhances recognition of the 59 ss by the spliceosome.
Alternatively, the G runs may favor the interaction of hnRNPH/F
with the spliceosome and enhance either the ATP-independent
[13] or the ATP-dependent steps of spliceosomal assembly [40].
The greater representation of genes that are enhanced by
hnRNPH/F in some categories of alternatively spliced events led
us to conclude that hnRNPH/F more frequently activate exon
inclusion in these events. It is possible that this result represents a
skewed detection in our arrays on the basis of a stronger effect on
genes that are enhanced vs. those that are inhibited by hnRNPH/
F. However, we think that this is unlikely. Our data are in keeping
with those reported by a genome wide analysis of human cells
showing that hnRNPH1, F, M and U activate exon inclusion for a
majority of types of ASEs [15]. Furthermore, knock down of
hnRNPH/F also reduced inclusion of the alternatively spliced
exon of most apoptotic genes examined by RT-PCR in cancer
cells [39]. Interestingly, none of the alternatively spliced events
examined in the latter study were significantly changed in our
microarrays. The absence of overlaps with splicing events
identified in that study may reflect the nature of the cells and
the methodologies used in each study. We have performed the
PLOS ONE | www.plosone.org

analysis in non cancer cells and we have used microarrays that
have a different dynamic range than the RT-PCR detection
method used in the other study.
We have also examined the effect of depletion of both
hnRNPH/F vs. depletion of each individually. We were interested
in determining whether a cooperative effect similar to that we
described for PLP is utilized for other 59 ASE. We show that for
the 59 ASEs that displayed a significant change upon knock down
of both hnRNPH/F, the effect of hnRNPH and F is additive and
their function is redundant as the individual knock down has a
smaller effect or no effect. It remains to be determined what
elements in the gene structure would determine this outcome vs.
the cooperative effect active in the PLP gene. An important
difference is that PLP is a cell-specific ASE, while the 59ASEs
identified in the arrays are not, suggesting that cell specific factors
may contribute to the synergism.
A novel finding of our study is that 6% of genes are regulated at
the expression level with two thirds being down regulated by knock
down of hnRNPH/F. Interestingly, 16% were also regulated at
the exon level compared to 9% of the total expressed genes,
suggesting a splicing dependent regulation of gene expression.
Additionally, hnRNPH/F may regulate gene expression by an
7
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Figure 5. Expression profile of the validated genes in developing oligodendrocytes in vivo. CNPase-EGFP+ oligodendrocytes were
isolated at post-natal day (P) 1, 10 and 21 [43] and subjected to RT-PCR, Western blot analysis and Real Time RT-PCR. A. Representative RT-PCR of
PLP/DM20 ratio and Western blot analysis of hnRNPH and F in developing oligodendrocytes. CNPase is a marker of differentiation and increases in
P10 and P21 OL vs. P1 oligodendrocyte progenitor cells. b-tubulin is the loading control. B. Bar graphs represent the mean 6 SD of transcript levels of
the indicated genes quantitated by Real Time RT-PCR in EGFP+ oligodendrocytes in vivo (n = 3). The fold change detected in the microarray is shown
in parenthesis next to the gene name. ns = non statistically significant. **#0.01.
doi:10.1371/journal.pone.0051266.g005

transcription, possibly indirectly by affecting genes involved in
transcriptional regulation. An important conclusion of the results is
that expression of genes that inhibit OL differentiation, cdk2 and
SOX6, is reduced by knock down of hnRNPH/F while genes that
promote OL differentiation, CREB and IGF1 are increased. In
addition, the increased expression of IGF1 suggests a possible
autocrine mechanism by which OL may regulate lineage
progression.
These data suggest that hnRNPH/F might regulate OL
proliferation and differentiation. In support of this statement, we
show that the expression of hnRNPH/F decreases in developing
OL in vivo at the time of the other gene expression changes.
Interestingly, hnRNPH and F decrease according to a distinct
temporal pattern suggesting that each factor may serve independent functions. Importantly, IGF1 and hnRNPA2/B1 demonstrated a biphasic pattern of expression, i.e. high at p21, when
both hnRNPH and F are decreased and low at p10, when
hnRNPH is still expressed, compared to p1, suggesting a
differential role of each hnRNPH and F on these genes. The
expression of other genes changed in the same direction at p21

RNA mediated mechanism by affecting message stability through
binding to G runs in the 39 UTR especially close to polyA sites
[41,42]. Interestingly, the 39 UTRs of the genes examined contain
multiple G triplets and long 4–6 G tracts, suggesting that a 39
UTR-mediated regulation may play a role (data not shown).
Another possibility is that depletion of hnRNPH/F causes a
change in the expression of other splicing factors. Cross-regulation
of hnRNPs was recently demonstrated in human cells after
depletion of individual hnRNPs [15], pointing to a complex
regulatory network. However, we did not detect significant
changes of other hnRNPs in our arrays, with the exception of
hnRNPA2/B1. Changes in the expression of SR proteins, Sfrs7,
Sfrs11 and Tra2a, were detected by arrays, but could not be
confirmed by subsequent Real Time qRT-PCR in Oli-neu cells
depleted of hnRNPH/F (data not shown).
Of the genes examined and involved in OL differentiation,
regulation at the exon level was detected for cdk2, SOX6 and
hnRNPA2/B1 after depletion of hnRNPH/F, suggesting that
changes in splicing may result in changes in transcript levels/
stability. For the other genes, hnRNPH and F may regulate
PLOS ONE | www.plosone.org
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Table S4 G tract analysis in the exon upstream and
intron downstream of the regulated 59 splice site for
internal exons. The Table shows the position, sequence and
length of exonic and intronic G tracts for 190 exons whose splicing
is affected by depletion of hnRNPH/F. Twenty one are alternative
first exons and one hundred and sixty nine are internal exons
(cassette and unknown). We show the gene ID number, gene
name, the regulated exon and whether the exon is down- or upregulated. The G tracts are color labeled depending on the length
of the G run.
(XLSX)

and p10. These patterns are likely to reflect their individual roles
in OL lineage progression, the mixed nature of OL development
at p10 and/or be influenced by the different temporal course of
hnRNPH/F decreased expression. Future studies will investigate
the role of hnRNPH and F in gene regulation in developing OL.
In summary, our studies show that hnRNPH/F exert a broad
effect on regulation of splicing and gene expression in OL.
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Table S5 List of genes with biological relevance for
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sequences of the forward and reverse primers used for RT-PCR
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Table S2 Sequences of Real Time qRT-PCR primers.
The sequences of the forward and reverse primers used for Real
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